Filing Details
- Accession Number:
- 0001209191-22-041499
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-07 17:12:16
- Reporting Period:
- 2022-07-05
- Accepted Time:
- 2022-07-07 17:12:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1720580 | Adicet Bio Inc. | ACET | Pharmaceutical Preparations (2834) | 813305277 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1886986 | Blake Aftab | C/O Adicet Bio, Inc. 200 Clarendon Street, Floor 6 Boston MA 02116 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-05 | 1,363 | $14.50 | 52,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Includes 1,363 shares purchased under the Issuer's Amended and Restated 2018 Employee Stock Purchase Plan on June 30, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
Billionaire Hedge Funds
